Global Systemic Lupus Erythematosus Report, 10-Year Forecasts, 7MM Coverage and Detailed Pipeline Product Profiles

News provided by

Apr 01, 2020, 08:00 ET

DUBLIN, April 1, 2020 /PRNewswire/ -- The "Systemic Lupus Erythematosus (SLE) - Epidemiology Forecast - 2028" report has been added to ResearchAndMarkets.com's offering.

According to the American College of Rheumatology Systemic lupus erythematosus, referred to as SLE or lupus, is a chronic (long-term) disease that causes systemic inflammation which affects multiple organs. In addition to affecting the skin and joints, it can affect other organs in the body such as the kidneys, the tissue lining the lungs (pleura), heart (pericardium), and brain. Many patients experience fatigue, weight loss, and fever.

SLE is most commonly seen in women in the reproductive age group (frequently starting at childbearing age), although lupus is increasingly recognized after the age of 40 years, particularly in the Europeans. The disease is prone to relapses and remissions, resulting in considerable morbidity due to flares of disease activity and accumulated organ damage, and an increased risk of premature death, mostly due to infection or cardiovascular disease.

The Systemic Lupus Erythematosus epidemiology division provides insights about historical and current patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Diagnosed Prevalent cases, Gender-Specific Prevalence, and Severity-Specific Prevalence(Mild, Moderate and Severe)) scenario of Systemic Lupus Erythematosus in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017 to 2028.

Among 7MM, the United States has the highest prevalent population of Systemic Lupus Erythematosus with about 259,474 cases in 2017. Among EU-5 countries, UK had the highest number of prevalent cases with approximately 62,852 cases, followed by Italy in 2017. Germany had the least number of prevalent cases, while in Japan, the diagnosed prevalent population of Systemic Lupus Erythematosus was found to be approximately 58,168.

Systemic Lupus Erythematosus Report Insights

The report covers a descriptive overview of the Systemic Lupus Erythematosus, explaining its causes, risk factors, pathophysiology, and diagnosis.
Comprehensive insight has been provided into the epidemiology Systemic Lupus Erythematosus in the 7MM countries covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Assesses growth opportunities in 7MM countries with respect to the patient population.

Systemic Lupus Erythematosus Report Key Strengths

10-Year Forecast
7MM Coverage
Diagnosed Prevalent Patient Pool of Systemic Lupus Erythematosus
Gender-Specific Diagnosed Patient Pool of Systemic Lupus Erythematosus
Severity-Specific Diagnosed Patient Pool of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Report Assessment

Current Treatment Practices
Unmet Needs
Detailed Pipeline Product Profiles

Key Benefits

Key assessments
Patient Segmentation
Disease Risk & Burden
Risk of disease by type

For more information about this report visit https://www.researchandmarkets.com/r/hp0udg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets